AngioDynamics (NASDAQ:ANGO) Downgraded by Raymond James to "Outperform"
Raymond James downgraded shares of AngioDynamics (NASDAQ:ANGO – Get Rating) from a strong-buy rating to an outperform rating in a report released on Monday morning, Marketbeat.com reports. The brokerage currently has $13.00 price target on the medical instruments supplier’s stock, down from their previous price target of $14.00. Separately, StockNews.com assumed coverage on shares of […]
United States Dave Helsel Raymond James Financial Services Group Inc Mutual Of America Capital Management Brinker Capital Investments
Source: theenterpriseleader.com